Delivery Order SPE2DX22D0049-SPE2D826FA0EU
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,954.56 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle. The place of performance is located in Conshohocken, Pennsylvania, which serves as...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $30,225.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,173.44 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 4, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $16,292.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,073.52 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, was competitively awarded without set-aside designation. AmerisourceBergen's place of performance is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,889.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was awarded competitively with no...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,267.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on September 6, 2025, with an ultimate completion date of September 8, 2025, was competitively awarded with no set-aside designation. The award represents a child contract under AmerisourceBergen's broader relationship...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $16,605.04 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,946.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 4, 2025, with an ultimate completion date of October 6, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA0EUDelivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,907.53 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price, non-set-aside delivery order is performed in Conshohocken, Pennsylvania, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award reflects the company's role as a critical pharmaceutical and medical supply distributor for federal healthcare procurement, particularly supporting military and veteran healthcare systems through competitive contract mechanisms. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. As a prime vendor under this vehicle, AmerisourceBergen serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning the company within DLA's Pharmaceutical Prime Vendor program structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.9k | 10/6/25 |